TRANSCAN-3 launches its fourth transnational call (JTC 2024)

With the support of 21 funding organisations from 16 different countries, TRANSCAN-3 has launched a call for research proposals on the topic of:

TRANSCAN-3 launches its fourth transnational call (JTC 2024)
TRANSCAN-3 launches its fourth transnational call (JTC 2024)

Combination therapies against cancer: new opportunities for translational research

The expected impact of the call is to improve the efficacy of personalized treatment of cancer patients through the development of new combinatorial treatment strategies, based on a better understanding of drug mechanistic functions and of their impact on the disease course. The specific objectives of this funding opportunity are to stimulate new partnerships between researchers and clinicians and support original, high-quality projects, with significant clinical impact.

For further information, please visit our dedicated JTC 2024 Webpage.

Timeline of the Call

27 March 2024

Publication of the call pre-announcement

26 April 2024

Publication of the call

26 April 2024 at 16:00 (CEST)

Opening of the on-line submission system for pre-proposals

05 July 2024 at 12:00 (CEST)

Deadline for pre-proposal submission

18 October 2024

 

Communication of the results of the pre-proposal assessment and invitation for full-proposal stage

18 November 2024

 

Opening of the submission system for full proposals

29 November 2024 at 12:00 (CET)

Deadline for full-proposal submission

Expected for May 2025

Communication of the funding decisions to the applicants

September 2025

Expected project start (also subject to regional/national procedures)